Direct Medical Cost of Managing Deep Vein Thrombosis According to the Occurrence of Complications
- 1 August 2002
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 20 (9) , 603-615
- https://doi.org/10.2165/00019053-200220090-00004
Abstract
Background:Management of deep vein thrombosis (DVT) has evolved from hospitalisation for intravenous heparin therapy to treatment options that include acute management as an outpatient. While...Keywords
This publication has 27 references indexed in Scilit:
- Heparin-Induced ThrombocytopeniaDrugs & Aging, 2000
- The Use of Automated Data to Identify Complications and Comorbidities of DiabetesJournal of Clinical Epidemiology, 1999
- Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis A feasibility and health economic study in an outpatient settingJournal of Internal Medicine, 1996
- Management of Deep Vein Thrombosis and Pulmonary EmbolismCirculation, 1996
- A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at HomeNew England Journal of Medicine, 1996
- Nursing Home Residents: A Multiwiate Analysis of Their Medical, Behavioral, Psychosocial, and Service Use CharacteristicsThe Journals of Gerontology: Series A, 1995
- How Accurate are Hospital Discharge Data for Evaluating Effectiveness of Care?Medical Care, 1993
- HeparinNew England Journal of Medicine, 1991
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986